| 1 |
LU2387456671 |
Franklin Genomic Advancements Fund - I (acc) EUR |
+50,17 % |
+21,98 % |
2,16 |
| 2 |
LU2346866317 |
Candriam Equities L Oncology, N - Capitalisation |
+37,51 % |
+16,40 % |
2,13 |
| 3 |
IE000G3N3NE7 |
Janus Henderson Global Life Sciences Fund G2 EUR |
+35,17 % |
+15,53 % |
2,10 |
| 4 |
LU2387457729 |
Franklin Genomic Advancements Fund - N (acc) EUR |
+47,64 % |
+22,02 % |
2,04 |
| 5 |
IE00BRJG6X20 |
Janus Henderson Global Life Sciences Fund I2 EUR |
+34,05 % |
+15,49 % |
2,03 |
|
|
| 212 |
LU1849505026 |
Protea Fund - Sectoral Healthcare Opportunities Fund PH EUR |
+12,68 % |
+15,31 % |
0,66 |
|
|
| 338 |
LU0580275534 |
Bellevue Funds (Lux) - Bellevue Medtech & Services HB EUR - Accumulating |
-14,51 % |
+16,46 % |
-1,04 |
| 339 |
LU0969575645 |
Variopartner SICAV - MIV Global Medtech Fund I3 USD |
-16,28 % |
+17,30 % |
-1,09 |
| 340 |
LU1050446076 |
Variopartner SICAV - MIV Global Medtech Fund N3 USD |
-16,45 % |
+17,30 % |
-1,10 |
| 341 |
LU0969575561 |
Variopartner SICAV - MIV Global Medtech Fund P3 USD |
-16,78 % |
+17,30 % |
-1,12 |
| 342 |
LU0580237955 |
Bellevue Funds (Lux) - Bellevue Medtech & Services HB CHF - Accumulating |
-16,04 % |
+16,45 % |
-1,13 |